Genetic and environmental background of HD, AD, PD, and ALS
HD | AD | PD | ALS | |
---|---|---|---|---|
Genetic background | Monogenic autosomal dominant inheritance
| Monogenic forms with autosomal dominant inheritance: PSEN1, PSEN2, APP GWAS highlights genes expressed in immune tissues | Monogenic forms
| Monogenic forms
|
Smoking | + | + | – | + |
Diabetes | ? | + | + | – |
Hypertension | + | + | + (?) | + (systolic)– (diastolic) |
Statins | – | – (?) | – | 0 |
Coffee | + | – (?) | – | 0 |
TBI | ? | + | + | + |
NSAIDs | ? | – | 0 | 0 |
Selected characteristics are presented and compared with no intent to perform an exhaustive review. “+” denotes increased risk of disease or its severity while “–” denotes a decreased risk. No association is marked by “0” and uncertainty with “?”. GWAS: genome-wide association study; NSAIDs: non-steroidal anti-inflammatory drugs; TBI: traumatic brain injury; CAG: cytosine-adenine-guanine; CAA: cytosine-adenine-adenine; PSEN1: presenilin 1; APP: amyloid precursor protein; LRRK2: leucine-rich repeat kinase 2; VPS35: vacuolar protein sorting 35; PRKN: parkin RBR E3 ubiquitin protein ligase; PINK1: PTEN-induced kinase 1; DJ1: PD protein 7; XDP: X-linked dystonia-parkinsonism; FUS: fused in sarcoma; OPTN: optineurin; VAPB: vesicle-associated membrane protein-associated protein B/C; UBQLN2: ubiquilin 2